NIFTY
-64.15  -0.56%
 11456.90
S&P BSE SENSEX
-222.14  -0.58%
 38164.61
Aurobindo Pharma Ltd.
NSE : AUROPHARMA BSE : 524804 ISIN code : INE406A01037
on 22-Mar-2019
NSE
-8.3    -1.07%
Rs. 768.30
 
Days Low
Rs. 763.7
Days High
Rs. 786.7

Open Rs. 777.3
 
52 week Low
Rs. 527.05
52 week High
Rs.830
 
 
Bid :                 0.00 (0)
Offer :        769.15 (102)
BSE
Rs.769.15
-8.1    -1.04%
on 22-Mar-2019
BSE
-8.1    -1.04%
Rs. 769.15
 
Days Low
Rs. 762.15
Days High
Rs. 786.9

Open Rs. 779
 
52 week Low
Rs. 527
52 week High
Rs.830.45
 
 
Bid :                 0.00 (0)
Offer :        769.15 (102)
NSE
Rs.768.30
-8.3    -1.07%
 
 
Last Price (Rs.)  769.15 Value  50274505.00
Net Change (Rs.)  -8.10 Best Buy  0.00
Volume  65150 Best Sell  769.15
Prev.Close (Rs.)  777.25 Best Quantity  0
Open (Rs.)  777.30 Sell Quantity  102
High (Rs.)  786.70 52-Week High (Rs.)  830.00
Low (Rs.)  763.70 52-Week Low (Rs.)  527.05
Face Value (Rs.)  1 Market Cap.(Rs/ Mn)  450650.84
 
BSE
You need to upgrade your Flash Player
 
Financial (Rs .in Million)
Balance Sheet
Share Capital585.90 585.90 585.20 
Share Capital585.90 585.90 585.20 
Share Capital585.90 585.90 585.20 
Share Capital585.90 585.90 585.20 
Share Capital585.90 585.90 585.20 
Currents Investments0.20 0.20 0.20 
More> 
 
Top 5 PeerCompanies * (Rs .in Million)
Company NameLTP* M.CapBVP/EDiv.Yield
Sun Pharma Inds. 473.15 1135245 77.46 0.00 0.42
Piramal Enterprises 2599.45 479455 1083.86 90.37 0.96
Dr. Reddys Lab 2748.90 456499 749.81 80.49 0.73
Divis Lab 1663.50 441607 251.75 50.78 0.60
Cipla 526.85 424484 186.99 28.88 0.57
 
Mutual Funds Holdings
Scheme Name% HoldNo.Shares
HDFC Balanced Advantage Fund(G) 1.63 8570828
HDFC Hybrid Equity Fund(G) 2.26 6761000
HDFC Equity Fund(G) 1.92 5457526
HDFC Top 100 Fund(G) 1.74 3632450
SBI BlueChip Fund-Reg(G) 1.24 3497861
 
Quarterly Result
(Rs .in millions)Dec 2018Sep 2018Jun 2018
Net Sales32481.0031703.9025588.20
Operating Profit7351.906111.503995.80
PBDT6937.805803.503757.10
Net Profit4635.103809.502251.20
More> 
 
Company News
3/20/2019 12:00:00 AM
Voting Results Of Postal Ballot
3/5/2019 12:00:00 AM
Announcement under Regulation 30 (LODR)-Updates on Acquisition
3/2/2019 12:00:00 AM
Aurobindo Pharma informs about acquisition
More>
 
Ratios
   Earnings Per Share (Rs)30.94 
   Book NAV/Share(Rs)170.38 
   PAT Margin (%)17.59 
   Asset Turnover(x)0.71 
   PER(x)18.01 
   Yield(%)0.45 
   EV/Core EBITDA(x)13.13 
   M Cap / Sales3.18 
   Net Sales Growth(%)6.90 
   PAT Growth(%)6.21 
   Total Debt/Equity(x)0.37 
   Current Ratio(x)1.56 
   Quick Ratio(x)0.97 
   Total Debt/Mcap(x)0.11 
More>